ExPrimary
Rockville, US · Founded 2013 · Delaware corporation · 1 known investors
Exprimary develops bioanalytical instrumentation and assay products at reduced cost for research and diagnostic markets. The company focuses on enabling personalized healthcare by improving access to bioanalysis tools globally.
BiotechDigital HealthMedical Devices
Founders & leadership
SH
Sean HigginsExecutive Officer, Director
HA
Holly AtleeExecutive Officer
SS
Scott StelickExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$35KraisedJan 2022 · 3 investors · BiotechnologyRule 506(b)
▶$35KraisedJan 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sean HigginsExecutive Officer, Director
- Holly AtleeExecutive Officer
- Scott StelickExecutive Officer
- Offering amount
- $750K
- Amount sold
- $35K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$10KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott StelickExecutive Officer
- Holly AtleeExecutive Officer
- Sean HigginsExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $10K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$35KraisedNov 2016 · 1 investors · BiotechnologyRule 506(b)
▶$35KraisedNov 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sean HigginsExecutive Officer, Director
- Holly AtleeExecutive Officer
- Scott StelickExecutive Officer
- Offering amount
- $65K
- Amount sold
- $35K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.